Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome

Journal of Autoimmune Diseases

Volumn 2, Issue , 2005, Pages

  Vernon, Suzanne D ^a   Reeves, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CELL ANTIGEN; CELL NUCLEUS ANTIGEN; DNA; MICROTUBULE ASSOCIATED PROTEIN 2;

ADULT; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOBLOTTING; MALE; PHYSICIAN; SERUM; UNITED STATES;

EID: 23044500863     PISSN: 17402557     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-2-5     Document Type: Article

References (17)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 1994, 121:953-959.
2. Afari N, Buchwald D: Chronic fatigue syndrome: a review. Am J Psychiatry 2003, 60:221-236.
3. Nisenbaum R, Reyes M, Unger ER, Reeves WC: Factor analysis of symptoms among subjects with unexplained chronic fatigue: What can we learn about chronic fatigue syndrome? J Psychosom Res 2004, 56:171-178.
4. Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM: Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996, 98:1888-1896.
5. Skowera A, Stewart E, Davis ET, Cleare AJ, Unwin C, Hull L, Ismail K, Hossain G, Wessely SC, Peakman M: Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients. Clin Exp Immunol 2002, 129:354-358.
6. Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi KI, Takano T, Kanakura Y, Amino N: Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med 2003, 12:225-230.
7. Reyes M, Gary HE, Dobbins JG, Randall B, Steele L, Fukuda K, Holmes GP, Connell DG, Mawle AC, Schmid DS, Stewart JA, Schonberger LB, Gunn WJ, Reeves WC: Surveillance for chronic fatigue syndrome - four US cities, September 1988 through August 1993. MMWR CDC Surveillance Summaries 1997, 46:2-13.
8. Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, Stewart JA, Abbey S, Jones JF, Gantz N, Minden S, Reeves WC: Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003, 163:1530-1536.
9. Reyes M, Dobbins JG, Mawle AC, Steele L, Gary HE, Malani H, Schmid S, Fukuda K, Stewart J, Nisenbaum R, Reeves WC: Risk factors for CFS: a case control study. J CFS 1996, 2:17-33.
10. Mawle AC, Nisenbaum R, Dobbins JG, Gary HE, Stewart JA, Reyes M, Steele L, Schmid DS, Reeves WC: Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997, 175:136-141.
11. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, et al.: Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988, 108:387-389.
12. Solomon L, Reeves WC: Factors influencing the diagnosis of chronic fatigue syndrome by primary health care providers. Arch Intern Med 2004, 164:2241-2245.
13. von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM: High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997, 40:295-305.
14. Williams RC Jr, Sugiura K, Tan EM: Antibodies to microtubuleassociated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004, 50:1239-1247.
15. Mawle AC, Nisenbaum R, Dobbins JG, Gary HE Jr, Stewart JA, Reyes M, Steele L, Schmid DS, Reeves WC: Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis 1995, 21:1386-9.
16. Pisetsky DS: Specificity and immunochemical properties of antibodies to bacterial DNA. Methods 1997, 11:55-61.
17. Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ: Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 2002, 28:347-352.